Recombinant antibodies: antibody sequencing and artificial intelligence help antibody design
2024-10-14
Antibodies can be synthesized through a variety of strategies, starting with polyclonal antibodies produced through animal immunization, followed by monoclonal antibodies produced ...
Hepatocyte growth factor receptor c-MET
2024-10-11
c-MET, also known as MET or hepatocyte growth factor receptor (HGFR), is a receptor tyrosine kinase belonging to the MET family. Hepatocyte growth factor (HGF) is a specific ligand...
The role of glycosylation in cancer and clinical therapy
2024-10-09
BackgroundGlycosylation is a key protein modification in vivo, playing an important role in regulating various biological functions by influencing protein folding, transport, and l...
The target of angiogenesis regulation is DLL4
2024-10-08
DLL4, short for delta-like protein 4, is a Notch ligand that participates in the Notch signaling pathway, activating NOTCH1 and NOTCH4. It is involved in angiogenesis and negativel...
Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer
2024-10-08
BackgroundCancer immunotherapy, represented by immune checkpoint inhibitors (ICIs), has reshaped the treatment paradigm for advanced non-small cell lung cancer and small cell lung ...
Autoimmune cancer testicular antigen NY-ESO-1
2024-09-26
NY-ESO-1, also known as CTA1B (CTAG1B), is an autoimmune cancer antigen presented on the cell surface by major histocompatibility complex class I molecules and exhibits restri...
The hepatocellular carcinoma marker GPC3
2024-09-24
Glypican-3 (GPC3) is a member of the heparan sulfate (HS) proteoglycan family. Anchored to the cell membrane via phosphatidylinositol, it serves as a multifunctional co-receptor on...